AACR Virtual Annual Meeting I: A Global Perspective of COVID-19 in Patients with Cancer
At the time of this writing, more than 3.3 million individuals have been diagnosed with COVID-19, and more than 222,000 have died from the...
“We Have to Be Involved” – A Preview of the AACR Virtual Meeting on COVID-19 and Cancer
The COVID-19 pandemic continues to impact the United States and other parts of the world. To date, 13 million cases have been...
AACR Virtual Meeting I & II: Platforms for COVID-19 and Cancer Discussions
The COVID-19 pandemic remains at the center of health and science news as cases of the disease continue to rise...
AACR COVID-19 and Cancer Virtual Meeting: The Distressing Intersection of the Pandemic and Noncommunicable Diseases
The COVID-19 pandemic has taken an enormous global toll. Worldwide, nearly 15 million cases of the disease have been reported,...
AACR COVID-19 and Cancer Virtual Meeting: Disparities During the Pandemic
At the American Association for Cancer Research (AACR), we know that our mission to prevent and cure all cancers must encompass all...
AACR COVID-19 and Cancer Virtual Meeting: Dr. Fauci Launches Meeting with Keynote Address
The AACR Virtual Meeting: COVID-19 and Cancer opened Monday with a keynote address from the nation’s leading infectious disease expert, Anthony Fauci, MD, the director of the National Institutes of Allergy and Infectious Diseases. Well...
AACR Annual Meeting 2021: Building COVID-19 Vaccine Confidence
Week 1 of the AACR Annual Meeting 2021 wrapped up on Thursday. The meeting drew more than 13,500 attendees...
AACR COVID-19 and Cancer Report: Patients, Policymakers, and Researchers Share Their Stories
Guest post by Patrick Williams, PhDAACR Scientific Research Analyst In a virtual Congressional briefing on February 9, 2022, the...
Closing the Cancer Disparities Gap Broadened by COVID-19
As COVID-19 cases and death rates fall, and in-person activities resume, cancer centers once again fill their beds with...
AACR COVID-19 and Cancer Virtual Meeting: Cancer Researchers Shift Focus to the Pandemic
In the global battle against the COVID-19 pandemic, cancer researchers are proving to be formidable forces. Armed with deep...
AACR Disparities Meeting: Lessons Learned from the COVID-19 Pandemic
While cancer and COVID-19 are, biologically, very different diseases, they have shaken the world in surprisingly similar ways. Nearly...
Protecting Patients With Blood Cancers From COVID-19
Blood cancer patients are highly vulnerable to COVID-19 infection. Now mounting evidence suggests they may be also among the least protected...
Annual Meeting 2022: T Cells Provide Hope for Cancer Patients Facing COVID-19
Since COVID-19 first began its siege on the world, much of our scientific knowledge about the disease—and its source...
COVID-19 and Cancer Consortium Forms to Collect and Share Information
Guest post by Jeremy Warner, MD, MS, and Deborah Doroshow, MD, PhD The world is facing a pandemic unlike...
Cancer Screening and Early Detection During the COVID-19 Pandemic
As infections from SARS-CoV-2 began to rapidly spread across the United States in early 2020, many nonessential medical procedures, including cancer screenings, were...
AACR Releases Groundbreaking Report on COVID-19 and Cancer
The COVID-19 pandemic has taken a devastating toll, with 5.8 million deaths worldwide, including nearly 1 million in the...
Patient Advocate Forum Explores the Effects of COVID-19
As the coronavirus pandemic took root in the United States, many hospitals and cancer centers temporarily suspended treatments and...
AACR Virtual Meeting on COVID-19 and Cancer: “Lightspeed” Vaccine Development—How Did They Do It?
On December 31, 2019, the first cases of “a pneumonia of unknown cause”—now known to be COVID-19—were reported in China, and the initial confirmed...
SABCS 2021: How Are Breast Cancer Survivors Navigating Life During the COVID-19 Pandemic?
When Abigail Johnston’s first child entered preschool six years ago, a vigilant pediatrician recommended an unusual strategy for minimizing...
SABCS 2020: Managing Breast Cancer During the COVID-19 Pandemic
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
Decades of Cancer Vaccine Research Enabled Rapid Development of COVID-19 Vaccines
Editor’s note: This post was written by Nicholas Warren, PhD, science policy program administrator in the AACR’s Office of...
The AACR and 140 Organizations Send Letter to President Biden Requesting High COVID-19 Vaccine Priority for Cancer Patients and Survivors
The American Association for Cancer Research (AACR) last week led a contingent of 140 organizations, cancer centers, and other...
AACR COVID-19 and Cancer Virtual Meeting: A Roundup of Blog Posts
As the COVID-19 pandemic began crossing the globe, scientists from many disciplines anticipated its scope and deployed their research...
AACR COVID-19 and Cancer Virtual Meeting: Developing Diagnostic Tests for SARS-CoV-2 Detection
“The development of tests that can identify individuals actively infected with SARS-CoV-2 is of obvious and utmost importance for...
AACR COVID-19 and Cancer Virtual Meeting: Tracking the Evolution and Spread of SARS-CoV-2
In January, when most of us in the United States were busy living the hustle and bustle of everyday life, one shrewd virologist and computer biologist saw...
COVID-19 and Cancer: Assessing the Impact of Disruptions to Care
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today The nationwide shutdown of elective clinical procedures implemented in...
Experts Forecast Cancer Research and Treatment Advances in 2021
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...
Do Patients With Cancer Have Prolonged Viral Shedding Following Infection With SARS-CoV-2?
Numerous studies have shown that individuals with cancer fare worse than the general population if they contract COVID-19, with...
Experts Forecast Cancer Research and Treatment Advances in 2022
The year 2021 defied our expectations in a variety of ways. The delta and omicron COVID-19 variants imposed unprecedented...
Editors’ Picks: August Highlights from the AACR Journals
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...